Genmab — April 2015
-
Støtten lå i 525...Den blev testet flere gange. Da den så ikke kunne holde så susede kursen videre ned.
-
Genmab fik også flere tæv end andre ved forrige ryk ned i bioteksektoren. Det er ikke så lang tid siden.
-
Aktier med volatilitet er godt ved daytrading for dem som kan finde ud af den slags.
-
Det virker dog ikke som om der er mange der gør det i Genmab. Her vi fleste vist lange.
-
Det kræver bare så lige, at man sidder og kigger ind i skærmen fra morgen til aften.
-
Ditto her. Dog ser jeg af og til nogle mønstre som jeg handler på med små beløb intraday. Det kræver så, at jeg har tid til at følge med ved skærmen hele tiden. Det har jeg så meget sjældent.
-
Lige nu lurer jeg på om der skal købes på tilbagefaldet. Jeg stoler dog ikke på, at anonyme ikke lige pludselig vælter en stor dyne ud inden luk.
-
jeg supplerede lidt i 510 .
-
In conclusion, the O-Dex regimen in relapsed/refractory CLL shows a relatively high ORR and CR, with a favorable PFS and OS (including subjects harboring p53 defects) when compared to published rituximab plus dexamethasone regimens, ofatumumab in monotherapy, and ofatumumab plus chemotherapy data.American Journal of Hematology
Volume 90, Issue 5, pages 417–421, May 2015
-
Ofatumumab remains a therapeutic option for patients who relapse after treatment with kinase inhibitors.the results of this study demonstrate that retreatment and maintenance with ofatumumab are feasible and can provide meaningful clinical benefit with an acceptable safety profile for patients with heavily pretreated CLL who had benefited from previous treatment with ofatumumab.
-
it appears likely that there will be a continued need for mAbs, including those targeting CD20, in the therapeutic arsenal for advanced-phase CLL, either in combination with a small therapeutic molecule, such as the kinase inhibitors, or as treatment for patients who do not respond to or show poor tolerability to such agents
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind